ArticleClinical & experimental metastasis2004

Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839).

Stephen Hiscox et al.PubMed ↗Publisher ↗

No numbers read from the abstract.